FDA Inspection
Medoz Pharmacy of Polk IncMedoz Pharmacy of Polk Inc – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns Medoz Pharmacy of Polk Inc, with an inspection on August 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dbe91bc9-69ba-41b3-b5b3-6e61278e43aa
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1099150
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
9- FDCA 501(a)(2)(A)Unsealed HEPA filter, perimeter
- FDCA 501(a)(2)(A)Personnel habits, contamination
- FDCA 501(a)(2)(A)Improper gowning, contamination
- FDCA 501(a)(2)(A)Personnel contact on container or closure
- FDCA 501(a)(2)(A)No sporicidal agents, cleanroom and ISO 5 area
- FDCA 501(a)(2)(A)Cleanliness, ISO-classified areas
- FDCA 501(a)(2)(A)Vermin, adjacent area
- FDCA 501(a)(2)(A)Vermin, production area
- FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medoz Pharmacy of Polk Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medoz Pharmacy of Polk Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.